Eye Disease, Hereditary Completed Phase 2 Trials for Valproic acid (DB00313)

IndicationStatusPhase
DBCOND0052875 (Eye Disease, Hereditary)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01399515Efficacy and Safety of Oral Valproic Acid for Retinitis PigmentosaTreatment